Abstract:Antimicrobial resistance is one of the most complex global health challenges today. The world has long ignored warnings that some antibiotics are losing effectiveness after decades of overuse and misuse in human medicine, animal health and agriculture. Antivirals, antiparasitic agents and antifungals are also becoming increasingly ineffective. Though we live in an age of technology and innovation, we could soon find ourselves in an era where simple infections kill millions of people every year. Common illnesses like bacterial pneumonia, post-operative infections, certain cancers, as well as the world's biggest infectious killers--tuberculosis, human immunodeficiency virus (HIV) and malaria--are increasingly difficult to treat because of the emergence and spread of drug resistance. (1) Worsening antimicrobial resistance could have serious public health, economic and social implications around the world. The World Bank has warned that antimicrobial resistance could cause as much damage to the global economy as the 2008 financial crisis. (2) Antimicrobial resistance can only be tackled through a concerted global effort, led by heads of state and global institutions, and through coordinated action by the health and agricultural sectors, in partnership with the food industry, campaign groups and community organizations. Governments need closely aligned policies on the responsible use of medicines in human and animal health, and new standards for antibiotic use in agriculture and food production. A one health approach, involving close coordination among all relevant sectors and actors, should be urgently implemented by all governments. In the past two years, we have seen global political momentum for addressing antimicrobial resistance. In May 2015, at the Sixty-eighth World Health Assembly, governments adopted a global action plan which identifies a set of strategic objectives. (1,3) In 2016, the United Nations General Assembly held the first high-level meeting on antimicrobial resistance and passed a political declaration. (4) The issue has also been on the agenda of recent group of seven (G7) and group of twenty (G20) meetings. Since May 2015, progress has also been made in the implementation of these global commitments. Over one hundred countries have completed, or are about to complete, their national multisectoral action plans. WHO has established a global antimicrobial resistance surveillance system to track which drug-resistant pathogens are posing the biggest challenge. (5) In May 2016, the Drugs for Neglected Diseases initiative and WHO launched a global research and development partnership to develop new antibiotics and promote their responsible use. (6) In August 2016, WHO updated its guidelines for the prevention and treatment of the three common sexually transmitted infections--chlamydia, gonorrhoea and syphilis. …

Antimicrobial Shortages: A Global Issue Impacting Infectious Diseases

Shortages Without Frontiers: Antimicrobial Drug and Vaccine Shortages Impact Far Beyond the Individual!

A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages

Drug Shortage: Causes, Impact, and Mitigation Strategies

In Shortage: Understanding Global Antibiotic Supply Chains Through Pharmaceutical Trade Fairs

Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability

Addressing Challenges in Antibiotic Access: Barriers, Implications and Strategies for Solution

New Agents Are Coming, and so Is the Resistance

Antimicrobial Resistance: A Growing Serious Threat for Global Public Health

Antimicrobial Resistance: Translating Political Commitment into National Action

Antibiotic resistance: a global crisis, problems and solutions

The Potential Impact of the COVID-19 Pandemic on Global Antimicrobial and Biocide Resistance: an AMR Insights Global Perspective

Antimicrobials and Antibiotic-Resistant Bacteria: A Risk to the Environment and to Public Health

Drug shortages. Part 2: Trends, causes and solutions

Improving equitable access for effective antibacterial: an ecosystem approach

Antimicrobial resistance: a concise update

Antimicrobial Resistance: What Lies Beneath This Complex Phenomenon?

The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies

Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps

The scope of the antimicrobial resistance challenge

Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance